SILVERARC CAPITAL MANAGEMENT, LLC Holdings

SILVERARC CAPITAL MANAGEMENT, LLC is an investment fund managing more than 295.64M US dollars. The largest holdings include BELLUS Health, Relmada Therapeutics and Prometheus Biosciences. In Q3 2022 the fund bought assets of total value of 92.83M US dollars and sold assets of total value of 70.39M US dollars.

$295.64M

portfolio value

+7.72%

quarter

-14.67%

1 year

SILVERARC CAPITAL MANAGEMENT, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2021	65731000	50651000
Q2 2021	91491000	60948000
Q3 2021	52892000	84832000
Q4 2021	83195000	30597000
Q1 2022	42256000	54172000
Q2 2022	79390000	77203000
Q3 2022	92826000	70391000

SILVERARC CAPITAL MANAGEMENT, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology BELLUS Health Inc. Portfolio share: 5.91% Portfolio value: 17.48M Avg. open price: $6.36 Current price: $10.2 P/L: +60.26% Bought +5.94% shares Q3 2022	share	5.91%	17.48M	$6.36	$10.2	+60.26%	Bought +5.94% shares Q3 2022
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 4.92% Portfolio value: 14.54M Avg. open price: N/A Current price: $4.6 P/L: N/A N/A Q3 2022	put	4.92%	14.54M	N/A	$4.6	N/A	N/A Q3 2022
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 4.09% Portfolio value: 12.07M Avg. open price: N/A Current price: $40 P/L: N/A Sold -32.15% shares Q3 2022	put	4.09%	12.07M	N/A	$40	N/A	Sold -32.15% shares Q3 2022
Biotechnology Veracyte, Inc. Portfolio share: 3.74% Portfolio value: 11.05M Avg. open price: $37.22 Current price: $29.14 P/L: -21.71% Sold -7.36% shares Q3 2022	share	3.74%	11.05M	$37.22	$29.14	-21.71%	Sold -7.36% shares Q3 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 3.46% Portfolio value: 10.21M Avg. open price: $9.94 Current price: $45.46 P/L: +357.16% Bought +15.24% shares Q3 2022	share	3.46%	10.21M	$9.94	$45.46	+357.16%	Bought +15.24% shares Q3 2022
Biotechnology Anavex Life Sciences Corp. Portfolio share: 3.29% Portfolio value: 9.72M Avg. open price: $10.01 Current price: $12.05 P/L: +20.38% Bought +2.77% shares Q3 2022	put	3.29%	9.72M	$10.01	$12.05	+20.38%	Bought +2.77% shares Q3 2022
Biotechnology Morphic Holding, Inc. Portfolio share: 3.11% Portfolio value: 9.18M Avg. open price: $42.88 Current price: $28.62 P/L: -33.25% Sold -22.51% shares Q3 2022	share	3.11%	9.18M	$42.88	$28.62	-33.25%	Sold -22.51% shares Q3 2022
Biotechnology Cogent Biosciences, Inc. Portfolio share: 3.06% Portfolio value: 9.05M Avg. open price: $8.06 Current price: $12.91 P/L: +60.17% Sold -26.11% shares Q3 2022	share	3.06%	9.05M	$8.06	$12.91	+60.17%	Sold -26.11% shares Q3 2022
Biotechnology Poseida Therapeutics, Inc. Portfolio share: 3.05% Portfolio value: 9.01M Avg. open price: $2.7 Current price: $4.92 P/L: +81.91% Bought +571.11% shares Q3 2022	share	3.05%	9.01M	$2.7	$4.92	+81.91%	Bought +571.11% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 3.00% Portfolio value: 8.88M Avg. open price: $25.13 Current price: $38.89 P/L: +54.75% Bought +5.74% shares Q3 2022	share	3.00%	8.88M	$25.13	$38.89	+54.75%	Bought +5.74% shares Q3 2022
Diagnostics & Research Aclaris Therapeutics, Inc. Portfolio share: 2.90% Portfolio value: 8.55M Avg. open price: $17.43 Current price: $16.64 P/L: -4.52% Bought +0.78% shares Q3 2022	share	2.90%	8.55M	$17.43	$16.64	-4.52%	Bought +0.78% shares Q3 2022
Medical Devices ViewRay, Inc. Portfolio share: 2.86% Portfolio value: 8.46M Avg. open price: $3.49 Current price: $4.78 P/L: +37.12% Bought +217.17% shares Q3 2022	share	2.86%	8.46M	$3.49	$4.78	+37.12%	Bought +217.17% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 2.69% Portfolio value: 7.94M Avg. open price: $16.58 Current price: $23.06 P/L: +39.10% Bought +2.83% shares Q3 2022	put	2.69%	7.94M	$16.58	$23.06	+39.10%	Bought +2.83% shares Q3 2022
Biotechnology Mersana Therapeutics, Inc. Portfolio share: 2.27% Portfolio value: 6.72M Avg. open price: $10.31 Current price: $7.25 P/L: -29.68% Bought +16.95% shares Q3 2022	share	2.27%	6.72M	$10.31	$7.25	-29.68%	Bought +16.95% shares Q3 2022
Biotechnology Prothena Corporation plc Portfolio share: 2.26% Portfolio value: 6.66M Avg. open price: N/A Current price: $65 P/L: N/A N/A Q3 2022	share	2.26%	6.66M	N/A	$65	N/A	N/A Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 2.20% Portfolio value: 6.51M Avg. open price: N/A Current price: $234.4 P/L: N/A N/A Q3 2022	share	2.20%	6.51M	N/A	$234.4	N/A	N/A Q3 2022
Biotechnology Veru Inc. Portfolio share: 2.14% Portfolio value: 6.33M Avg. open price: N/A Current price: $5.5 P/L: N/A Sold -29.52% shares Q3 2022	put	2.14%	6.33M	N/A	$5.5	N/A	Sold -29.52% shares Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 2.14% Portfolio value: 6.33M Avg. open price: $45.83 Current price: $54.08 P/L: +18.00% Sold -56.64% shares Q3 2022	share	2.14%	6.33M	$45.83	$54.08	+18.00%	Sold -56.64% shares Q3 2022
Medical Devices Apollo Endosurgery, Inc. Portfolio share: 2.12% Portfolio value: 6.26M Avg. open price: $6.9 Current price: $10.08 P/L: +46.07% Bought +5.71% shares Q3 2022	share	2.12%	6.26M	$6.9	$10.08	+46.07%	Bought +5.71% shares Q3 2022
Biotechnology Merus N.V. Portfolio share: 2.00% Portfolio value: 5.91M Avg. open price: $24.32 Current price: $14.97 P/L: -38.44% Sold -37.09% shares Q3 2022	share	2.00%	5.91M	$24.32	$14.97	-38.44%	Sold -37.09% shares Q3 2022
Medical Devices Cerus Corporation Portfolio share: 1.97% Portfolio value: 5.81M Avg. open price: $5.99 Current price: $4.15 P/L: -30.67% Sold -22.80% shares Q3 2022	share	1.97%	5.81M	$5.99	$4.15	-30.67%	Sold -22.80% shares Q3 2022
Biotechnology CTI BioPharma Corp. Portfolio share: 1.94% Portfolio value: 5.72M Avg. open price: $2.48 Current price: $5.99 P/L: +141.53% Sold -28.74% shares Q3 2022	share	1.94%	5.72M	$2.48	$5.99	+141.53%	Sold -28.74% shares Q3 2022
Biotechnology Clene Inc. Portfolio share: 1.64% Portfolio value: 4.85M Avg. open price: N/A Current price: $1.07 P/L: N/A N/A Q3 2022	put	1.64%	4.85M	N/A	$1.07	N/A	N/A Q3 2022
Biotechnology Insmed Incorporated Portfolio share: 1.63% Portfolio value: 4.82M Avg. open price: $24.34 Current price: $20.37 P/L: -16.30% Bought +5.43% shares Q3 2022	share	1.63%	4.82M	$24.34	$20.37	-16.30%	Bought +5.43% shares Q3 2022
Biotechnology Nkarta, Inc. Portfolio share: 1.61% Portfolio value: 4.76M Avg. open price: $12.32 Current price: $8.59 P/L: -30.28% Bought +227.16% shares Q3 2022	share	1.61%	4.76M	$12.32	$8.59	-30.28%	Bought +227.16% shares Q3 2022
Biotechnology Pliant Therapeutics, Inc. Portfolio share: 1.48% Portfolio value: 4.38M Avg. open price: N/A Current price: $17.83 P/L: N/A N/A Q3 2022	share	1.48%	4.38M	N/A	$17.83	N/A	N/A Q3 2022
Biotechnology Acumen Pharmaceuticals, Inc. Portfolio share: 1.43% Portfolio value: 4.21M Avg. open price: N/A Current price: $5.6 P/L: N/A N/A Q3 2022	share	1.43%	4.21M	N/A	$5.6	N/A	N/A Q3 2022
Biotechnology Krystal Biotech, Inc. Portfolio share: 1.34% Portfolio value: 3.94M Avg. open price: $66.54 Current price: $77.5 P/L: +16.47% Sold -46.19% shares Q3 2022	share	1.34%	3.94M	$66.54	$77.5	+16.47%	Sold -46.19% shares Q3 2022
Biotechnology ORIC Pharmaceuticals, Inc. Portfolio share: 1.31% Portfolio value: 3.86M Avg. open price: $4.48 Current price: $4.2 P/L: -6.25% Bought +11.71% shares Q3 2022	share	1.31%	3.86M	$4.48	$4.2	-6.25%	Bought +11.71% shares Q3 2022
Biotechnology Vertex Pharmaceuticals Incorporated Portfolio share: 1.09% Portfolio value: 3.21M Avg. open price: $243.68 Current price: $321.37 P/L: +31.88% Bought +6.64% shares Q3 2022	share	1.09%	3.21M	$243.68	$321.37	+31.88%	Bought +6.64% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 1.08% Portfolio value: 3.18M Avg. open price: $16.58 Current price: $23.06 P/L: +39.10% N/A Q3 2022	share	1.08%	3.18M	$16.58	$23.06	+39.10%	N/A Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 1.00% Portfolio value: 2.96M Avg. open price: $171.36 Current price: $96.25 P/L: -43.83% Sold -57.88% shares Q3 2022	call	1.00%	2.96M	$171.36	$96.25	-43.83%	Sold -57.88% shares Q3 2022
Biotechnology Crinetics Pharmaceuticals, Inc. Portfolio share: 0.99% Portfolio value: 2.92M Avg. open price: $21.2 Current price: $18.42 P/L: -13.12% Bought +6.80% shares Q3 2022	share	0.99%	2.92M	$21.2	$18.42	-13.12%	Bought +6.80% shares Q3 2022
Biotechnology REGENXBIO Inc. Portfolio share: 0.98% Portfolio value: 2.91M Avg. open price: $24.7 Current price: $24.26 P/L: -1.78% Bought +5.72% shares Q3 2022	share	0.98%	2.91M	$24.7	$24.26	-1.78%	Bought +5.72% shares Q3 2022
Biotechnology Cullinan Oncology, Inc. Portfolio share: 0.97% Portfolio value: 2.87M Avg. open price: $12.82 Current price: $12.11 P/L: -5.54% Bought +5.38% shares Q3 2022	share	0.97%	2.87M	$12.82	$12.11	-5.54%	Bought +5.38% shares Q3 2022
Medical Devices CVRx, Inc. Portfolio share: 0.97% Portfolio value: 2.87M Avg. open price: $6.01 Current price: $14.44 P/L: +140.27% Bought +5.40% shares Q3 2022	share	0.97%	2.87M	$6.01	$14.44	+140.27%	Bought +5.40% shares Q3 2022
Biotechnology LAVA Therapeutics N.V. Portfolio share: 0.94% Portfolio value: 2.79M Avg. open price: N/A Current price: $7.31 P/L: N/A N/A Q3 2022	share	0.94%	2.79M	N/A	$7.31	N/A	N/A Q3 2022
Biotechnology Allakos Inc. Portfolio share: 0.83% Portfolio value: 2.44M Avg. open price: N/A Current price: $8.32 P/L: N/A N/A Q3 2022	share	0.83%	2.44M	N/A	$8.32	N/A	N/A Q3 2022
Biotechnology Seres Therapeutics, Inc. Portfolio share: 0.80% Portfolio value: 2.35M Avg. open price: $19.74 Current price: $7.13 P/L: -63.88% Bought +5.39% shares Q3 2022	share	0.80%	2.35M	$19.74	$7.13	-63.88%	Bought +5.39% shares Q3 2022
Biotechnology BioCryst Pharmaceuticals, Inc. Portfolio share: 0.80% Portfolio value: 2.35M Avg. open price: $10.58 Current price: $12.79 P/L: +20.89% Bought +248.65% shares Q3 2022	share	0.80%	2.35M	$10.58	$12.79	+20.89%	Bought +248.65% shares Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 0.79% Portfolio value: 2.32M Avg. open price: N/A Current price: $236.82 P/L: N/A N/A Q3 2022	share	0.79%	2.32M	N/A	$236.82	N/A	N/A Q3 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 0.78% Portfolio value: 2.31M Avg. open price: $5.73 Current price: $6.75 P/L: +17.80% N/A Q3 2022	share	0.78%	2.31M	$5.73	$6.75	+17.80%	N/A Q3 2022
Biotechnology United Therapeutics Corporation Portfolio share: 0.76% Portfolio value: 2.24M Avg. open price: $173.11 Current price: $278.55 P/L: +60.91% Sold -34.09% shares Q3 2022	share	0.76%	2.24M	$173.11	$278.55	+60.91%	Sold -34.09% shares Q3 2022
Health Information Services Phreesia, Inc. Portfolio share: 0.72% Portfolio value: 2.12M Avg. open price: $25.01 Current price: $28.7 P/L: +14.75% Bought +6.65% shares Q3 2022	share	0.72%	2.12M	$25.01	$28.7	+14.75%	Bought +6.65% shares Q3 2022
Drug Manufacturers—Specialty & Generic Esperion Therapeutics, Inc. Portfolio share: 0.71% Portfolio value: 2.10M Avg. open price: N/A Current price: $7.39 P/L: N/A N/A Q3 2022	share	0.71%	2.10M	N/A	$7.39	N/A	N/A Q3 2022
Biotechnology ImmunoGen, Inc. Portfolio share: 0.71% Portfolio value: 2.09M Avg. open price: $5.95 Current price: $5.47 P/L: -8.09% Bought +5.33% shares Q3 2022	share	0.71%	2.09M	$5.95	$5.47	-8.09%	Bought +5.33% shares Q3 2022
Biotechnology Arvinas, Inc. Portfolio share: 0.61% Portfolio value: 1.81M Avg. open price: N/A Current price: $41.39 P/L: N/A N/A Q3 2022	share	0.61%	1.81M	N/A	$41.39	N/A	N/A Q3 2022
Biotechnology Intellia Therapeutics, Inc. Portfolio share: 0.61% Portfolio value: 1.79M Avg. open price: N/A Current price: $46.12 P/L: N/A N/A Q3 2022	share	0.61%	1.79M	N/A	$46.12	N/A	N/A Q3 2022
Biotechnology Immunovant, Inc. Portfolio share: 0.57% Portfolio value: 1.67M Avg. open price: N/A Current price: $14.68 P/L: N/A N/A Q3 2022	share	0.57%	1.67M	N/A	$14.68	N/A	N/A Q3 2022
Biotechnology Immatics N.V. Portfolio share: 0.55% Portfolio value: 1.63M Avg. open price: $11.53 Current price: $11.26 P/L: -2.36% Sold -53.83% shares Q3 2022	share	0.55%	1.63M	$11.53	$11.26	-2.36%	Sold -53.83% shares Q3 2022
Biotechnology BioAtla, Inc. Portfolio share: 0.52% Portfolio value: 1.54M Avg. open price: N/A Current price: $10.52 P/L: N/A N/A Q3 2022	share	0.52%	1.54M	N/A	$10.52	N/A	N/A Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.51% Portfolio value: 1.49M Avg. open price: $34.09 Current price: $37.34 P/L: +9.55% Bought +46.67% shares Q3 2022	share	0.51%	1.49M	$34.09	$37.34	+9.55%	Bought +46.67% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 0.49% Portfolio value: 1.45M Avg. open price: $146.25 Current price: $122.41 P/L: -16.30% Sold -73.95% shares Q3 2022	share	0.49%	1.45M	$146.25	$122.41	-16.30%	Sold -73.95% shares Q3 2022
Biotechnology 89bio, Inc. Portfolio share: 0.49% Portfolio value: 1.44M Avg. open price: $24.37 Current price: $8.41 P/L: -65.49% N/A Q3 2022	share	0.49%	1.44M	$24.37	$8.41	-65.49%	N/A Q3 2022
Biotechnology Trevi Therapeutics, Inc. Portfolio share: 0.49% Portfolio value: 1.44M Avg. open price: N/A Current price: $2.13 P/L: N/A N/A Q3 2022	share	0.49%	1.44M	N/A	$2.13	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Amryt Pharma plc Portfolio share: 0.44% Portfolio value: 1.30M Avg. open price: $11.81 Current price: $7.15 P/L: -39.47% Bought +6.80% shares Q3 2022	share	0.44%	1.30M	$11.81	$7.15	-39.47%	Bought +6.80% shares Q3 2022
Biotechnology Eliem Therapeutics, Inc. Portfolio share: 0.44% Portfolio value: 1.29M Avg. open price: $8.39 Current price: $2.62 P/L: -68.75% Sold -43.61% shares Q3 2022	share	0.44%	1.29M	$8.39	$2.62	-68.75%	Sold -43.61% shares Q3 2022
Biotechnology Altimmune, Inc. Portfolio share: 0.43% Portfolio value: 1.28M Avg. open price: N/A Current price: $11.28 P/L: N/A N/A Q3 2022	share	0.43%	1.28M	N/A	$11.28	N/A	N/A Q3 2022
Biotechnology NGM Biopharmaceuticals, Inc. Portfolio share: 0.42% Portfolio value: 1.23M Avg. open price: $12.82 Current price: $5.59 P/L: -56.40% Bought +7.04% shares Q3 2022	share	0.42%	1.23M	$12.82	$5.59	-56.40%	Bought +7.04% shares Q3 2022
Biotechnology Anavex Life Sciences Corp. Portfolio share: 0.35% Portfolio value: 1.03M Avg. open price: $10.01 Current price: $12.05 P/L: +20.38% N/A Q3 2022	call	0.35%	1.03M	$10.01	$12.05	+20.38%	N/A Q3 2022
Biotechnology Codexis, Inc. Portfolio share: 0.30% Portfolio value: 881K Avg. open price: $19.44 Current price: $5.67 P/L: -70.83% Bought +5.42% shares Q3 2022	share	0.30%	881K	$19.44	$5.67	-70.83%	Bought +5.42% shares Q3 2022
Biotechnology EyePoint Pharmaceuticals, Inc. Portfolio share: 0.29% Portfolio value: 857K Avg. open price: $10.85 Current price: $3.39 P/L: -68.76% Sold -45.21% shares Q3 2022	share	0.29%	857K	$10.85	$3.39	-68.76%	Sold -45.21% shares Q3 2022
Biotechnology Nuvalent, Inc. Portfolio share: 0.27% Portfolio value: 806K Avg. open price: N/A Current price: $36.03 P/L: N/A N/A Q3 2022	share	0.27%	806K	N/A	$36.03	N/A	N/A Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 0.24% Portfolio value: 714K Avg. open price: $171.36 Current price: $96.25 P/L: -43.83% Sold -71.93% shares Q3 2022	share	0.24%	714K	$171.36	$96.25	-43.83%	Sold -71.93% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.21% Portfolio value: 627K Avg. open price: $91.38 Current price: $104.85 P/L: +14.74% Sold -85.97% shares Q3 2022	share	0.21%	627K	$91.38	$104.85	+14.74%	Sold -85.97% shares Q3 2022
Medical Instruments & Supplies Stereotaxis, Inc. Portfolio share: 0.21% Portfolio value: 623K Avg. open price: $4.93 Current price: $2.3 P/L: -53.32% Sold -6.08% shares Q3 2022	share	0.21%	623K	$4.93	$2.3	-53.32%	Sold -6.08% shares Q3 2022
Biotechnology Compass Therapeutics, Inc. Portfolio share: 0.20% Portfolio value: 598K Avg. open price: N/A Current price: $4.94 P/L: N/A N/A Q3 2022	share	0.20%	598K	N/A	$4.94	N/A	N/A Q3 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 0.17% Portfolio value: 516K Avg. open price: $166.78 Current price: $125.39 P/L: -24.82% N/A Q3 2022	share	0.17%	516K	$166.78	$125.39	-24.82%	N/A Q3 2022
Biotechnology MeiraGTx Holdings plc Portfolio share: 0.16% Portfolio value: 465K Avg. open price: $7.57 Current price: $6.38 P/L: -15.72% Bought +6.29% shares Q3 2022	share	0.16%	465K	$7.57	$6.38	-15.72%	Bought +6.29% shares Q3 2022
Biotechnology MacroGenics, Inc. Portfolio share: 0.12% Portfolio value: 346K Avg. open price: N/A Current price: $6.9 P/L: N/A N/A Q3 2022	share	0.12%	346K	N/A	$6.9	N/A	N/A Q3 2022
Biotechnology Prothena Corporation plc Portfolio share: 0.10% Portfolio value: 303K Avg. open price: N/A Current price: $65 P/L: N/A N/A Q3 2022	put	0.10%	303K	N/A	$65	N/A	N/A Q3 2022
Biotechnology NuCana plc Portfolio share: 0.10% Portfolio value: 282K Avg. open price: N/A Current price: $0.83 P/L: N/A N/A Q3 2022	share	0.10%	282K	N/A	$0.83	N/A	N/A Q3 2022
Biotechnology Praxis Precision Medicines, Inc. Portfolio share: 0.08% Portfolio value: 227K Avg. open price: N/A Current price: $2.19 P/L: N/A N/A Q3 2022	share	0.08%	227K	N/A	$2.19	N/A	N/A Q3 2022
Biotechnology Eloxx Pharmaceuticals, Inc. Portfolio share: 0.06% Portfolio value: 187K Avg. open price: $1.5 Current price: $4.13 P/L: +175.19% Bought +5.47% shares Q3 2022	share	0.06%	187K	$1.5	$4.13	+175.19%	Bought +5.47% shares Q3 2022
Biotechnology Evogene Ltd. Portfolio share: 0.05% Portfolio value: 139K Avg. open price: $3.06 Current price: $0.63 P/L: -79.38% Sold -17.21% shares Q3 2022	share	0.05%	139K	$3.06	$0.63	-79.38%	Sold -17.21% shares Q3 2022
Biotechnology Terns Pharmaceuticals, Inc. Portfolio share: 0.03% Portfolio value: 85K Avg. open price: N/A Current price: $6.41 P/L: N/A N/A Q3 2022	share	0.03%	85K	N/A	$6.41	N/A	N/A Q3 2022
Biotechnology PolyPid Ltd. Portfolio share: 0.02% Portfolio value: 59K Avg. open price: $8.33 Current price: $0.83 P/L: -90.04% N/A Q3 2022	put	0.02%	59K	$8.33	$0.83	-90.04%	N/A Q3 2022
RENOVACOR INC Portfolio share: 0.00% Portfolio value: 8K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.00%	8K	N/A	N/A	N/A	N/A Q3 2021
Medicus Sciences Acquisition Corp. Portfolio share: 0.00% Portfolio value: 1K Avg. open price: N/A Current price: $0.09 P/L: N/A N/A Q2 2021	share	0.00%	1K	N/A	$0.09	N/A	N/A Q2 2021
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $50.81 Current price: $50.63 P/L: -0.35% Sold -100.00% shares Q3 2022	share	0.00%	0	$50.81	$50.63	-0.35%	Sold -100.00% shares Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $234.4 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$234.4	N/A	Sold -100.00% shares Q3 2022
Biotechnology Otonomy, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $2.41 Current price: $0.14 P/L: -94.01% Sold -100.00% shares Q3 2022	share	0.00%	0	$2.41	$0.14	-94.01%	Sold -100.00% shares Q3 2022
Biotechnology Aligos Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $2.15 Current price: $0.96 P/L: -55.35% Sold -100.00% shares Q3 2022	share	0.00%	0	$2.15	$0.96	-55.35%	Sold -100.00% shares Q3 2022
Biotechnology Mereo BioPharma Group plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $3.35 Current price: $0.84 P/L: -75.03% Sold -100.00% shares Q3 2022	share	0.00%	0	$3.35	$0.84	-75.03%	Sold -100.00% shares Q3 2022
Invesco QQQ Trust Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $292.55 P/L: N/A Sold -100.00% shares Q3 2022	put	0.00%	0	N/A	$292.55	N/A	Sold -100.00% shares Q3 2022
SPDR S&P Biotech ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $113.24 Current price: $85.66 P/L: -24.36% Sold -100.00% shares Q3 2022	call	0.00%	0	$113.24	$85.66	-24.36%	Sold -100.00% shares Q3 2022
Biotechnology Humanigen, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.15 P/L: N/A Sold -100.00% shares Q3 2022	put	0.00%	0	N/A	$0.15	N/A	Sold -100.00% shares Q3 2022
Biotechnology Forma Therapeutics Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $20.01 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$20.01	N/A	Sold -100.00% shares Q3 2022
Biotechnology Silverback Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.87 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$5.87	N/A	Sold -100.00% shares Q3 2022
Biotechnology Syndax Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $20.91 Current price: $25.07 P/L: +19.89% Sold -100.00% shares Q3 2022	share	0.00%	0	$20.91	$25.07	+19.89%	Sold -100.00% shares Q3 2022
Biotechnology Day One Biopharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $21.74 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$21.74	N/A	Sold -100.00% shares Q3 2022
Biotechnology ContraFect Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.15 P/L: N/A Sold -100.00% shares Q3 2022	put	0.00%	0	N/A	$0.15	N/A	Sold -100.00% shares Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $15.98 Current price: $51.99 P/L: +225.39% Sold -100.00% shares Q3 2022	share	0.00%	0	$15.98	$51.99	+225.39%	Sold -100.00% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $34.09 Current price: $37.34 P/L: +9.55% Sold -100.00% shares Q3 2022	put	0.00%	0	$34.09	$37.34	+9.55%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $226.82 Current price: $298.9 P/L: +31.78% Sold -100.00% shares Q3 2022	share	0.00%	0	$226.82	$298.9	+31.78%	Sold -100.00% shares Q3 2022
Biotechnology Zymeworks Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $7.58 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$7.58	N/A	Sold -100.00% shares Q3 2022
Biotechnology Biohaven Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $110.04 Current price: $16.74 P/L: -84.79% Sold -100.00% shares Q3 2022	share	0.00%	0	$110.04	$16.74	-84.79%	Sold -100.00% shares Q3 2022
Biotechnology Compugen Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $6.74 Current price: $1.16 P/L: -82.78% Sold -100.00% shares Q3 2022	share	0.00%	0	$6.74	$1.16	-82.78%	Sold -100.00% shares Q3 2022
Biotechnology PolyPid Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $8.33 Current price: $0.83 P/L: -90.04% Sold -100.00% shares Q3 2022	share	0.00%	0	$8.33	$0.83	-90.04%	Sold -100.00% shares Q3 2022

Showing TOP 99 SILVERARC CAPITAL MANAGEMENT's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of SILVERARC CAPITAL MANAGEMENT, LLC?

The biggest position of the SILVERARC CAPITAL MANAGEMENT, LLC is BELLUS Health Inc. (BLU) with 5.91% portfolio share worth of 17.49M US dollars.

Top 5 SILVERARC CAPITAL MANAGEMENT's holdings represent 22.11% of the portfolio:

BELLUS Health Inc. (BLU) – 5.91%
Relmada Therapeutics, Inc. (RLMD) – 4.92%
Prometheus Biosciences, Inc. (RXDX) – 4.09%
Veracyte, Inc. (VCYT) – 3.74%
Akero Therapeutics, Inc. (AKRO) – 3.46%

Who is the portfolio manager of SILVERARC CAPITAL MANAGEMENT, LLC?

The portfolio manager of the SILVERARC CAPITAL MANAGEMENT, LLC is .

What is the total asset value of the SILVERARC CAPITAL MANAGEMENT, LLC portfolio?

SILVERARC CAPITAL MANAGEMENT, LLC total asset value (portfolio value) is 295.64M US dollars.

Who is ?

is the portfolio manager of the SILVERARC CAPITAL MANAGEMENT, LLC.

What is (SILVERARC CAPITAL MANAGEMENT, LLC) fund performance?

SILVERARC CAPITAL MANAGEMENT's quarterly performance is +7.72%, annualy -14.67%.

What is the SILVERARC CAPITAL MANAGEMENT, LLC CIK?

SILVERARC CAPITAL MANAGEMENT's Central Index Key is 0001816307 .